Atlas Trials

A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.

Clinical trial NCT07600788 · RECRUITING

Trial details

NCT number
NCT07600788
Sponsor
Ausper Biopharma Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2026-07-09
Primary completion
2028-05-15
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.